Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
about
A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factorsBasal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer.CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma.Expression and functionality of TRPV1 in breast cancer cells.Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis.Centrosome amplification: a suspect in breast cancer and racial disparities.Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression.Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery.Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells.A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response.NOTCH3 expression is linked to breast cancer seeding and distant metastasis
P2860
Q27323906-862B5F26-9EF3-4896-BAFC-BCF018B570E5Q33737278-D8249B2B-9835-41F8-A1BE-541711C7FD42Q35545648-0B3DDC41-5506-495D-B17E-2FB8F852C895Q36279794-62B42D68-BE90-43C6-B8CC-864FD2E7BDEDQ37252696-362C4257-5704-441C-B4D7-76C801E71C29Q37427855-982EB2E1-97C6-4B46-B242-361BCAC83D7CQ37515768-6EC46144-61B5-4FA2-8F0D-1288183508A0Q37716464-BEA0B27C-F90A-4EE7-94B4-AE5ECB7B1CCEQ37728190-BFC06C80-1F85-484B-B537-5B182FB67A2CQ38780267-910E2191-832F-4212-898E-55A61AC0FB23Q41663163-DCCEFA41-14BB-4F5D-9ABB-664A39B07601Q47108689-8DC1C579-34DA-4FD2-A6AE-C0BDE31B8737Q47148711-D66C964B-06C4-4642-8163-712592E10EDBQ52692110-F9CAC9C6-DEF6-4380-BB48-F23058785AD7Q58765230-AE30A9D4-54FC-4C32-85E5-88CB15669252
P2860
Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@ast
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@en
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@nl
type
label
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@ast
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@en
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@nl
prefLabel
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@ast
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@en
Inhibition of Cdk2 kinase acti ...... -negative breast cancer cells.
@nl
P2093
P2860
P50
P356
P1476
Inhibition of Cdk2 kinase acti ...... e-negative breast cancer cells
@en
P2093
Antonino B D'Assoro
Giuseppe Puccia
Ianko Iankov
James N Ingle
Jeffrey L Salisbury
Mario W Gambino
Mateusz Opyrchal
Mathew P Goetz
P2860
P304
P356
10.3892/IJO.2014.2523
P577
2014-06-25T00:00:00Z